Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
service testing
Viking Therapeutics’ weight-loss drug data makes company takeover target
Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%, as analysts weighed in on...
Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug
Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results from a Phase 2 trial of...
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development of a promising cancer treatment after...
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion, as the world’s top drugmakers rush...
